Provided by Tiger Trade Technology Pte. Ltd.

Cardinal Health

207.23
+0.83000.40%
Post-market: 207.230.00000.00%19:53 EDT
Volume:1.98M
Turnover:410.75M
Market Cap:48.76B
PE:29.84
High:208.72
Open:206.91
Low:203.86
Close:206.40
52wk High:233.60
52wk Low:120.72
Shares:235.32M
Float Shares:235.32M
Volume Ratio:0.84
T/O Rate:0.84%
Dividend:2.04
Dividend Rate:0.98%
EPS(TTM):6.94
EPS(LYR):6.48
ROE:-171.32%
ROA:3.50%
PB:-16.91
PE(LYR):31.99

Loading ...

U.S. Earnings Preview: Before Market Open Feb. 5

Dow Jones
·
Feb 05

Cardinal Health Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 05

Did Rising Focus on Cardinal Health's (CAH) Pricing Power Quietly Reframe Its Supply-Chain Moat?

Simply Wall St.
·
Feb 04

Cardinal Health Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jan 30

Morgan Stanley Raises Price Target on Cardinal Health to $245 From $224, Keeps Overweight Rating

MT Newswires Live
·
Jan 29

Earning Preview: Cardinal Health Q2 revenue is expected to increase by 16.56%, and institutional views are predominantly bullish

Earnings Agent
·
Jan 29

Cardinal Health Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jan 28

U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings

Reuters
·
Jan 27

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 27

Argus Research Adjusts Cardinal Health Price Target to $232 From $211, Maintains Buy Rating

MT Newswires Live
·
Jan 24

Crinetics doses first patient in BALANCE-CAH trial

TIPRANKS
·
Jan 23

Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)

GlobeNewswire
·
Jan 23

Jefferies Adjusts Cardinal Health Price Target to $270 From $220, Maintains Buy Rating

MT Newswires Live
·
Jan 22

U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies

Reuters
·
Jan 22

Cardinal Health Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Jan 15

Cardinal Health Inc : Bofa Global Research Raises Price Objective to $240 From $230

THOMSON REUTERS
·
Jan 15

Cardinal Health, Inc. : Wells Fargo Raises Target Price to $237 From $221

THOMSON REUTERS
·
Jan 15

Leerink Partners Adjusts Price Target on Cardinal Health to $240 From $230, Maintains Outperform Rating

MT Newswires Live
·
Jan 14

Cardinal Health Inc : Baird Raises Target Price to $250 From $232

THOMSON REUTERS
·
Jan 14

Cardinal Health Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 14